Number of respondents by (selected*) first cancer site and date of diagnosis: Medicare Advantage

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 24,551 8,114 33.0 4,076 16.6 4,059 16.5 5,165 21.0 3,137 12.8
Breast 22,668 7,110 31.4 3,216 14.2 2,939 13.0 4,158 18.3 5,245 23.1
Colorectal 13,538 6,057 44.7 1,896 14.0 1,556 11.5 1,903 14.1 2,126 15.7
Lung and Bronchial 11,617 8,917 76.8 1,331 11.5 567 4.9 467 4.0 335 2.9
Ovary 1,414 686 48.5 174 12.3 109 7.7 142 10.0 303 21.4
Uterine Corpus 3,901 1,037 26.6 463 11.9 431 11.0 653 16.7 1,317 33.8
Uterine Cervix 1,583 128 8.1 30 1.9 67 4.2 134 8.5 1,224 77.3
Bladder 6,298 3,037 48.2 915 14.5 717 11.4 804 12.8 825 13.1
Melanoma 6,962 2,863 41.1 990 14.2 946 13.6 1,034 14.9 1,129 16.2
Head and Neck 6,358 2,954 46.5 883 13.9 727 11.4 801 12.6 993 15.6
Kidney and Renal Pelvis 2,877 1,427 49.6 417 14.5 364 12.7 350 12.2 319 11.1
Non-Hodgkin Lymphomas 4,271 2,294 53.7 580 13.6 474 11.1 492 11.5 431 10.1
Leukemia 2,379 1,497 62.9 303 12.7 215 9.0 211 8.9 153 6.4
Stomach 1,414 931 65.8 196 13.9 81 5.7 101 7.1 105 7.4
Esophagus 739 561 75.9 80 10.8 48 6.5 33 4.5 17 2.3
Pancreas 2,019 1,835 90.9 112 5.5 35 1.7 20 1.0 17 0.8

*Sites reflect most prevalent cancer sites in SEER-CAHPS